221 related articles for article (PubMed ID: 28122072)
1. Chemotherapy Use and Survival Among Young and Middle-Aged Patients With Colon Cancer.
Manjelievskaia J; Brown D; McGlynn KA; Anderson W; Shriver CD; Zhu K
JAMA Surg; 2017 May; 152(5):452-459. PubMed ID: 28122072
[TBL] [Abstract][Full Text] [Related]
2. Overtreatment of young adults with colon cancer: more intense treatments with unmatched survival gains.
Kneuertz PJ; Chang GJ; Hu CY; Rodriguez-Bigas MA; Eng C; Vilar E; Skibber JM; Feig BW; Cormier JN; You YN
JAMA Surg; 2015 May; 150(5):402-9. PubMed ID: 25806815
[TBL] [Abstract][Full Text] [Related]
3. Utilization and impact of adjuvant chemotherapy among patients with resected stage II colon cancer: a multi-institutional analysis.
Ejaz A; Casadaban L; Maker AV
J Surg Res; 2017 Jul; 215():12-20. PubMed ID: 28688636
[TBL] [Abstract][Full Text] [Related]
4. Effect of adjuvant chemotherapy on survival benefit in stage III colon cancer patients stratified by age: a Japanese real-world cohort study.
Kawamura H; Morishima T; Sato A; Honda M; Miyashiro I
BMC Cancer; 2020 Jan; 20(1):19. PubMed ID: 31906959
[TBL] [Abstract][Full Text] [Related]
5. Randomized trial of adjuvant therapy in colon carcinoma: 10-year results of NSABP protocol C-01.
Smith RE; Colangelo L; Wieand HS; Begovic M; Wolmark N
J Natl Cancer Inst; 2004 Aug; 96(15):1128-32. PubMed ID: 15292384
[TBL] [Abstract][Full Text] [Related]
6. Benefit of adjuvant chemotherapy in patients with T4 UICC II colon cancer.
Teufel A; Gerken M; Hartl J; Itzel T; Fichtner-Feigl S; Stroszczynski C; Schlitt HJ; Hofstädter F; Klinkhammer-Schalke M
BMC Cancer; 2015 May; 15():419. PubMed ID: 25985893
[TBL] [Abstract][Full Text] [Related]
7. [Evaluation value of preoperative peripheral blood lymphocyte-to-monocyte ratio on the prognosis of patients with stage III colon cancer].
Chen J; Peng J; Fan W; Zhang R; Wang F; Zhou W; Xu D; Pan Z; Lu Z
Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Jan; 22(1):73-78. PubMed ID: 30703797
[TBL] [Abstract][Full Text] [Related]
8. Adjuvant chemotherapy is associated with improved survival in patients with stage II colon cancer.
Casadaban L; Rauscher G; Aklilu M; Villenes D; Freels S; Maker AV
Cancer; 2016 Nov; 122(21):3277-3287. PubMed ID: 27417445
[TBL] [Abstract][Full Text] [Related]
9. [Adjuvant chemotherapy in colon cancer. About 119 cases].
Yaich A; Khanfir A; Bayrouti MI; Frikha M
Tunis Med; 2015 Apr; 93(4):242-7. PubMed ID: 26375742
[TBL] [Abstract][Full Text] [Related]
10. High-Risk Stage II Colon Cancer: Not All Risks Are Created Equal.
Babcock BD; Aljehani MA; Jabo B; Choi AH; Morgan JW; Selleck MJ; Luca F; Raskin E; Reeves ME; Garberoglio CA; Lum SS; Senthil M
Ann Surg Oncol; 2018 Jul; 25(7):1980-1985. PubMed ID: 29675762
[TBL] [Abstract][Full Text] [Related]
11. Prevalence and survival benefit of adjuvant chemotherapy in stage III colon cancer patients: Comparison of overall and age-stratified results by multivariable modeling and propensity score methodology in a population-based cohort.
Hines RB; Bimali M; Johnson AM; Bayakly AR; Collins TC
Cancer Epidemiol; 2016 Oct; 44():77-83. PubMed ID: 27513721
[TBL] [Abstract][Full Text] [Related]
12. Delay in Adjuvant Chemotherapy and Survival Advantage in Stage III Colon Cancer.
Turner MC; Farrow NE; Rhodin KE; Sun Z; Adam MA; Mantyh CR; Migaly J
J Am Coll Surg; 2018 Apr; 226(4):670-678. PubMed ID: 29378259
[TBL] [Abstract][Full Text] [Related]
13. Perineural Invasion is a Major Prognostic and Predictive Factor of Response to Adjuvant Chemotherapy in Stage I-II Colon Cancer.
Cienfuegos JA; Martínez P; Baixauli J; Beorlegui C; Rosenstone S; Sola JJ; Rodríguez J; Hernández-Lizoáin JL
Ann Surg Oncol; 2017 Apr; 24(4):1077-1084. PubMed ID: 27624582
[TBL] [Abstract][Full Text] [Related]
14. Efficacy and toxicity of adjuvant chemotherapy in elderly patients with colon carcinoma: a 10-year experience of the Geisinger Medical Center.
Fata F; Mirza A; Craig G; Nair S; Law A; Gallagher J; Ellison N; Bernath A
Cancer; 2002 Apr; 94(7):1931-8. PubMed ID: 11932894
[TBL] [Abstract][Full Text] [Related]
15. Prognostic factors and the role of adjuvant chemotherapy in post-curative surgery for Dukes B and C colon cancers and survival outcomes: a Malaysian experience.
Hassan AS; Naicker M; Yusof KH; Wan Ishak WZ
Asian Pac J Cancer Prev; 2015; 16(6):2237-43. PubMed ID: 25824744
[TBL] [Abstract][Full Text] [Related]
16. Randomized Controlled Trial of Intraportal Chemotherapy Combined With Adjuvant Chemotherapy (mFOLFOX6) for Stage II and III Colon Cancer.
Chang W; Wei Y; Ren L; Zhong Y; Yu Y; Chen J; Zhu D; Ye L; Qin C; Zhao N; Niu W; Qin X; Xu J
Ann Surg; 2016 Mar; 263(3):434-9. PubMed ID: 26465781
[TBL] [Abstract][Full Text] [Related]
17. Prospectively randomized trial of postoperative adjuvant chemotherapy in patients with high-risk colon cancer.
O'Connell MJ; Laurie JA; Kahn M; Fitzgibbons RJ; Erlichman C; Shepherd L; Moertel CG; Kocha WI; Pazdur R; Wieand HS; Rubin J; Vukov AM; Donohue JH; Krook JE; Figueredo A
J Clin Oncol; 1998 Jan; 16(1):295-300. PubMed ID: 9440756
[TBL] [Abstract][Full Text] [Related]
18. Overuse and Limited Benefit of Chemotherapy for Stage II Colon Cancer in Young Patients.
Birkett RT; Chamely E; Concors SJ; Bleier JI; Aarons CB; Shanmugan S; Saur NM; Paulson EC
Clin Colorectal Cancer; 2019 Dec; 18(4):292-300. PubMed ID: 31447135
[TBL] [Abstract][Full Text] [Related]
19. Adjuvant chemotherapy use and outcomes of patients with high-risk versus low-risk stage II colon cancer.
Kumar A; Kennecke HF; Renouf DJ; Lim HJ; Gill S; Woods R; Speers C; Cheung WY
Cancer; 2015 Feb; 121(4):527-34. PubMed ID: 25332117
[TBL] [Abstract][Full Text] [Related]
20. Administration of adjuvant chemotherapy in older patients with Stage III colon cancer: an observational study.
van den Broek CBM; Puylaert CCEM; Breugom AJ; Bastiaannet E; de Craen AJM; van de Velde CJH; Liefers GJ; Portielje JEA
Colorectal Dis; 2017 Oct; 19(10):O358-O364. PubMed ID: 28873267
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]